Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Filing Description Date Filed Size   8-K current report Mar 10, 2010 21.1 KB SC 13G statement of beneficial ownership Mar 5, 2010 58.1 KB 8-K current report Mar 3, 2010 56.4 KB 4 bailey, gregory Feb 23, 2010 19.4 KB 4 machado, clarence patrick Feb 22, 2010 19.3 KB SC 13G/A amended statement of beneficial ownership Feb 16, 2010 44.2 KB SC 13G/A amended statement of beneficial ownership Feb 16, 2010 21.1 KB SC 13G/A amended statement of beneficial ownership Feb 12, 2010 57.0 KB 4 bailey, gregory Feb 11, 2010 19.4 KB 4 palekar, rohan Feb 3, 2010 21.3 KB SC 13G/A amended statement of beneficial ownership Feb 1, 2010 58.8 KB SC 13G statement of beneficial ownership Jan 29, 2010 24.9 KB 4 bailey, gregory Jan 29, 2010 19.4 KB SC 13G/A amended statement of beneficial ownership Jan 25, 2010 59.0 KB 4 machado, clarence patrick Jan 20, 2010 19.5 KB 4 bailey, gregory Jan 15, 2010 19.4 KB 4 blickenstaff, kim d Jan 15, 2010 21.3 KB 4 bailey, gregory Dec 23, 2009 19.4 KB 4 bailey, gregory Dec 22, 2009 19.4 KB 4 bailey, gregory Dec 18, 2009 19.4 KB Showing 1-20 of 484 Page: 1 2 3 ... 25  Next 20 = add filing to Briefcase